Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement

Circulation
G F MitchellM A Pfeffer

Abstract

There is increasing evidence of a link between conduit vessel stiffness and cardiovascular events, although the association has never been tested in a large post-myocardial infarction patient population. We evaluated the relationship between baseline pulse pressure, measured by sphygmomanometry 3 to 16 days after myocardial infarction, and subsequent adverse clinical events in the 2231 patients enrolled in the SAVE Trial. Increased pulse pressure was associated with increased age, left ventricular ejection fraction, female sex, history of prior infarction, diabetes, and hypertension and use of digoxin and calcium channel blockers. Over a 42-month period, there were 503 deaths, 422 cardiovascular deaths, and 303 myocardial infarctions. Pulse pressure was significantly related to each of these end points as a univariate predictor. In a multivariate analysis, pulse pressure remained a significant predictor of total mortality (relative risk, 1.08 per 10 mm Hg increment in pulse pressure; 95% CI, 1.00 to 1.17; P<.05) and recurrent myocardial infarction (relative risk, 1.12; 95% CI, 1.01 to 1.23; P<.05) after control for age; left ventricular ejection fraction; mean arterial pressure; sex; treatment arm (captopril or placebo); smokin...Continue Reading

References

Feb 1, 1989·Journal of Hypertension·B PannierM E Safar
May 2, 1989·The American Journal of Cardiology·D H Blankenhorn
Jun 1, 1985·American Heart Journal·J D BouthierA C Simon
Jul 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·W A RileyG S Berenson
Jan 1, 1987·Journal of Vascular Surgery·R T LyonC K Zarins
Mar 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A P AvolioM F O'Rourke
Jul 1, 1983·Journal of Cardiovascular Pharmacology·A C SimonA Benetos
Sep 26, 1983·The American Journal of Medicine·W B Kannel
May 1, 1983·The American Journal of Physiology·M M Walsh-Reitz, F G Toback
Oct 1, 1994·American Heart Journal·S S Franklin, M A Weber
Feb 1, 1994·American Journal of Hypertension·B M PannierM E Safar
Dec 1, 1993·Journal of the American College of Cardiology·P S SabaR B Devereux
May 1, 1993·Journal of the American College of Cardiology·H WatanabeY Sugishita
Nov 1, 1956·Journal of Applied Physiology·J W REMINGTON, E H WOOD

❮ Previous
Next ❯

Citations

Oct 7, 2004·Aging Clinical and Experimental Research·Morad AskariLewis A Lipsitz
Sep 22, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Colin J PetrieHenry J Dargie
Jun 11, 2008·Medical & Biological Engineering & Computing·Nico WesterhofBerend E Westerhof
May 28, 2009·Journal of General Internal Medicine·Avraham WeissEhud Grossman
Sep 22, 2007·Current Heart Failure Reports·J Cheriyan, Ian B Wilkinson
Sep 12, 2000·Current Hypertension Reports·C Vlachopoulos, M O'Rourke
May 7, 2004·Current Hypertension Reports·Michel E Safar
Sep 12, 2000·Current Hypertension Reports·J D Jackson, P Merat
Jul 12, 2003·Preventive Medicine·Wendy J MackHoward N Hodis
May 16, 2003·Lancet·Jan A StaessenWillem H Birkenhäger
Jul 18, 2000·Journal of the American College of Cardiology·V VaccarinoH M Krumholz
Nov 25, 2000·Journal of the American College of Cardiology·P AngererC von Schacky
Mar 27, 2001·Journal of the American College of Cardiology·A M Dart, B A Kingwell
Apr 13, 2001·Journal of the American College of Cardiology·H SmulyanM E Safar
Jul 14, 2001·Journal of the American College of Cardiology·R H FagardL Thijs
Jul 5, 2001·Journal of Clinical Epidemiology·F ThomasA Benetos
Aug 31, 2010·Acta Pharmacologica Sinica·Najeeb A Shirwany, Ming-hui Zou
Mar 18, 2005·Journal of Human Hypertension·C AlliUNKNOWN Studio sulla Pressione Arteriosa nell'Anziano(SPAA)
Jul 21, 2006·Journal of Human Hypertension·E A KarpanouD V Cokkinos
May 4, 1999·Clinical and Experimental Pharmacology & Physiology·J Cameron
Nov 13, 2001·Clinical and Experimental Pharmacology & Physiology·C N Martyn, S E Greenwald
Aug 11, 2000·Kidney International. Supplement·F MeeusG M London
Dec 1, 2011·Sexual Health·William Chan, Anthony M Dart
Aug 24, 1999·Current Opinion in Nephrology and Hypertension·G F Mitchell
Feb 27, 2001·Current Opinion in Nephrology and Hypertension·M E Safar
Feb 27, 2001·Current Opinion in Nephrology and Hypertension·J G Wang, J A Staessen
Jan 24, 2002·Blood Pressure Monitoring·L ThijsUNKNOWN Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
Jan 24, 2002·Blood Pressure Monitoring·P VerdecchiaC Porcellati
Dec 19, 2008·American Journal of Therapeutics·Rohit Arora, Ritika Khandpur
Jul 9, 2011·Current Opinion in Nephrology and Hypertension·Leopoldo Raij, Alba M Gonzalez-Ochoa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.